News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,775 Results
Type
Article (41358)
Company Profile (264)
Press Release (689137)
Multimedia
Podcasts (91)
Webinars (20)
Section
Business (204844)
Career Advice (2032)
Deals (35582)
Drug Delivery (128)
Drug Development (81516)
Employer Resources (173)
FDA (16511)
Job Trends (14982)
News (346826)
Policy (32751)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2595)
Accelerated approval (47)
Adcomms (26)
Allergies (171)
Alliances (49580)
ALS (210)
Alzheimer's disease (1796)
Antibody-drug conjugate (ADC) (446)
Approvals (16894)
Artificial intelligence (660)
Autoimmune disease (290)
Automation (56)
Bankruptcy (362)
Best Places to Work (11635)
BIOSECURE Act (20)
Biosimilars (221)
Biotechnology (173)
Bladder cancer (194)
Brain cancer (71)
Breast cancer (749)
Cancer (5810)
Cardiovascular disease (469)
Career advice (1724)
Career pathing (42)
CAR-T (331)
CDC (56)
Celiac Disease (3)
Cell therapy (897)
Cervical cancer (47)
Clinical research (70815)
Collaboration (2050)
Company closure (5)
Compensation (1394)
Complete response letters (80)
COVID-19 (2741)
CRISPR (107)
C-suite (1120)
Cystic fibrosis (152)
Data (7877)
Decentralized trials (3)
Denatured (27)
Depression (161)
Dermatology (86)
Diabetes (586)
Diagnostics (6927)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (316)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (283)
Earnings (92105)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119488)
Executive appointments (1079)
FDA (20231)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1719)
Gene editing (233)
Generative AI (56)
Gene therapy (720)
GLP-1 (1052)
Government (4732)
Grass and pollen (6)
Guidances (408)
Healthcare (18996)
HIV (79)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (287)
Immuno-oncology (93)
Indications (194)
Infectious disease (3078)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (288)
Interviews (319)
IPO (16667)
IRA (50)
Job creations (3647)
Job search strategy (1430)
JPM (58)
Kidney cancer (19)
Labor market (100)
Layoffs (562)
Leadership (39)
Legal (7953)
Liver cancer (100)
Longevity (32)
Lung cancer (762)
Lymphoma (429)
Machine learning (60)
Management (59)
Manufacturing (1045)
MASH (186)
Medical device (13929)
Medtech (14051)
Mergers & acquisitions (20160)
Metabolic disorders (1496)
mRNA (204)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (414)
Neuropsychiatric disorders (105)
Neuroscience (3300)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4530)
Now hiring (78)
Obesity (700)
Opinion (287)
Ovarian cancer (220)
Pain (253)
Pancreatic cancer (300)
Parkinson's disease (360)
Partnered (33)
Patents (593)
Patient recruitment (667)
Peanut (62)
People (59579)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22076)
Phase 2 (31201)
Phase 3 (23213)
Pipeline (8734)
Policy (316)
Postmarket research (2569)
Preclinical (9408)
Press Release (64)
Prostate cancer (303)
Psychedelics (54)
Radiopharmaceuticals (323)
Rare diseases (1073)
Real estate (5969)
Recruiting (70)
Regulatory (25393)
Reports (56)
Research institute (2412)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (288)
Series B (213)
Service/supplier (11)
Sickle cell disease (112)
Special edition (23)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3639)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (62)
Vaccines (1088)
Venture capital (108)
Weight loss (450)
Women's health (127)
Worklife (20)
Date
Today (114)
Last 7 days (839)
Last 30 days (3431)
Last 365 days (30102)
2026 (12521)
2025 (30171)
2024 (35210)
2023 (40072)
2022 (51174)
2021 (55708)
2020 (54081)
2019 (46537)
2018 (35016)
2017 (32108)
2016 (31479)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (39669)
Australia (6506)
California (13265)
Canada (3764)
China (1335)
Colorado (566)
Connecticut (577)
Delaware (407)
Europe (85842)
Florida (1984)
Georgia (425)
Hawaii (3)
Idaho (62)
Illinois (1050)
India (90)
Indiana (599)
Iowa (23)
Japan (538)
Kansas (131)
Kentucky (50)
Louisiana (40)
Maine (76)
Maryland (1589)
Massachusetts (9457)
Michigan (363)
Minnesota (716)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3491)
New Mexico (29)
New York (3469)
North Carolina (1683)
North Dakota (9)
Northern California (6648)
Ohio (396)
Oklahoma (23)
Oregon (41)
Pennsylvania (2670)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5236)
Tennessee (211)
Texas (2110)
United States (46783)
Utah (394)
Vermont (1)
Virginia (321)
Washington D.C. (80)
Washington State (1061)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
730,775 Results for "verastem inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Verastem Oncology to Present at Upcoming May 2026 Investor Conferences
May 12, 2026
·
1 min read
Press Releases
Verastem Oncology Launches HCP and Patient Reimagine Campaign to Increase Awareness of AVMAPKI® FAKZYNJA® CO-PACK for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
April 30, 2026
·
11 min read
Press Releases
Verastem Oncology Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
May 8, 2026
·
19 min read
Press Releases
Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
·
1 min read
Press Releases
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2026
April 3, 2026
·
1 min read
Press Releases
Verastem Oncology Announces Late Breaking and Regular Abstracts Accepted for Presentation at the AACR Annual Meeting 2026
March 18, 2026
·
8 min read
Press Releases
Verastem Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
February 18, 2026
·
1 min read
Press Releases
Verastem Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Business Updates
March 5, 2026
·
20 min read
Press Releases
Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancers
March 18, 2026
·
11 min read
Press Releases
Verastem Oncology Announces Two-Year Median Follow-Up Data on AVMAPKI® FAKZYNJA® Combination Therapy (avutometinib capsules; defactinib tablets) in Recurrent Low-Grade Serous Ovarian Cancer at the SGO 2026 Annual Meeting on Women’s Cancers
April 10, 2026
·
13 min read
1 of 73,078
Next
